Inclusion-Body Myositis

Course overview

Inclusion Body Myositis (IBM) is an idiopathic inflammatory myopathy, characterized by its inclusion within a group of muscle diseases that also includes polymyositis, dermatomyositis, and autoimmune necrotizing myopathies. Symptoms of IBM often include muscle weakness, particularly targeting the wrist, fingers, quadriceps, and anterior tibialis. Additional medical and physiological complexities, such as dysphagia and pulmonary complications, further complicate the condition. Diagnosing IBM requires a comprehensive understanding of its symptoms, underlying causes, and progression. The prevalence and life expectancy associated with IBM highlight the chronic nature of this disease, impacting the quality of life significantly. This course will cover the pharmaceutical considerations necessary for managing IBM, emphasizing the importance of a multidisciplinary team in treatment. Studies have shown the benefits of aerobic and muscle-strengthening exercises on serum CPK levels and inflammation, shedding light on exercise tolerance in IBM patients. Extensive research and literature provide valuable insights into IBM, guiding physical therapy treatment considerations and recommendations. Various resources will be made available to support the understanding and management of IBM throughout this course, preparing physical therapists and assistants to rehabilitate patients with IBM.